EVH
Evolent Health·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Consensus Rating "Strong Buy"
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About EVH
Evolent Health, Inc.
A health care company that delivers proven clinical and administrative solutions to payers and providers
Healthcare Technology
12/12/2014
06/05/2015
New York Stock Exchange
4,500
12-31
Common stock
1812 N. Moore Street, Suite 1705, Arlington, Virginia 22209
--
Evolent Health, Inc., founded in Delaware on December 12, 2014, is a market leader and pioneer, a new era of medical services and payments, and leading providers are taking responsibility for improving the clinical and financial aspects of the populations they serve. The company's dedicated platform, equipped with technology, proprietary processes and integrated services, enables service providers to migrate from FFS reimbursement to their economic direction to a value-based payment model.
Earnings Call
Company Financials
EPS
EVH has released its 2025 Q3 earnings. EPS was reported at 0.05, versus the expected 0.1, missing expectations. The chart below visualizes how EVH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
EVH has released its 2025 Q3 earnings report, with revenue of 479.53M, reflecting a YoY change of -22.83%, and net profit of -20.86M, showing a YoY change of 9.82%. The Sankey diagram below clearly presents EVH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available

